Vivo Bio Tech Limited submitted a regulatory compliance report to BSE Limited regarding the re-lodgement of transfer requests for physical shares. This submission was made in accordance with SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026.
The report was prepared and provided by the company's Registrar and Share Transfer Agent, M/s. Aarthi Consultants Private Limited, covering the period ended May 2026.
Status Report for May 2026
- Number of requests received during the month: NIL
- Number of requests processed during the month: NIL
- Number of requests approved during the month: NIL
- Number of requests rejected during the month: NIL
- Average time taken for processing of requests: NA
The document confirms that no shareholders utilized the special window provided by SEBI's circular for re-lodgement of physical share transfer requests during the reported period.
Signatories and Authentication
The submission was digitally signed by A V Kiran, Company Secretary of Vivo Bio Tech Limited, on June 06, 2026 at 16:36:50 IST. The enclosed report from Aarthi Consultants was signed by Jagan Mohan Gobburi, Compliance Officer.
Financial Impact
No financial impact disclosed. The report is purely informational regarding compliance with regulatory reporting requirements.